Rapid Antimicrobial Susceptibility Testing of Yersinia Pestis Strains from Kazakhstan Plague Foci

Tatyana V. Meka-Mechenko, Zaurbek A. Sagiyev, Elmira Zh. Begimbayeva, Larissa E. Nekrassova, Galina G. Kovaleva, Uinkul A. Izbanova, Larissa Y. Lukhnova, Tatyana K. Kunitsa, Saule K. Umarova

Ekoloji, 2017, Issue 102, Pages: 5-11, Article No: e102002

OPEN ACCESS

Download Full Text (PDF)

Abstract

As far as new antibiotic-resistant Yersinia pestis strains appear in the climate of bioterrorism threats, plague susceptibility to antibacterials requires regular testing. Yersinia pestis should be put through rapid antimicrobial susceptibility tests. Since it grows slowly on agar media, the rapid in vivo test is especially required. The purpose of this research is to study Yersinia pestis strains from different Kazakhstan plague foci and to design an easy and fast method of antibiotic susceptibility estimation. All Y.pestis strains were susceptible to antibacterial agents traditionally recommended for plague treatment. All isolates were susceptible to ß-lactam antibacterials, including imipenem, fluoroquinolones, aminoglycosides and doxycycline. We have not detected any resistant Y.pestis strains during a 10-year investigation. We showed that preliminary rapid AST allows getting indices in 3-6 hours from the moment of Y. pestis isolation. Therefore, we recommend it for making a preliminary choice of antibacterial agents for plague treatment using HiComb MIC test for getting results that are more accurate. Strains resistant to antibacterials have not been detected during the 10-year research. The V.I. Ilyukhin’s method and the HiComb MIC test are recommended for rapid assessment of microorganism sensitivity to chemotherapy and should be out by anti-plague institutions into practical contexts.

Keywords

Y.pestis, antibiotic susceptibility, plague foci, minimum inhibitory concentration, antibacterial agent

References

  • Aikimbayew A, Meka-Mechenko T, Temiralieva G, Bekenov J, Sagiyev Z, Kaljan K, Mukhambetova AK (2003) Plague peculiarities in Kazakhstan at the present time. Przeglad epidemiologiczny, 57(4): 593-598.
  • Anisimov AP, Lindler LE, Pier GB (2004) Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev., 17: 434–64.
  • Atlas RM (1998) Biological weapons pose challenge for microbiology community. ASM News, 64: 1–7.10.
  • Atshabar BB, Aikimbaev AM, Aubakirov SA, Suleimenov BM (2000) Epizootologic and social basis for plague human infection in 1999 in Kazakhstan and their clinical-epidemiologic characteristics. Problems of the Most Dangerous Infections, Saratov: 14-21.
  • Balakhonov SV, Bel’kova SA, Tokmakova EG, Khvoĭnova IG, Zakhlebnaia OD (2013) The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro. Klinicheskaia laboratornaia diagnostika, (4): 36-40.
  • Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. Journal of clinical microbiology, 37(5): 1415-1418.
  • Byrne WR, Welkos SL, Pitt ML, Davis KJ, Brueckner RP, Ezzell JW, ... Friedlander AM (1998) Antibiotic treatment of experimental pneumonic plague in mice. Antimicrobial agents and chemotherapy, 42(3): 675-681.
  • Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M (2012) Matrix-assisted laser desorption ionization–time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. Journal of clinical microbiology, 50(3): 927-937.
  • Chu MC (2000) Laboratory manual of plague diagnostic tests. CDC Publications. Atlanta, Ga, 129.
  • Clinical and Laboratory Standards Institute (2010) Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, 2nd ed. CLSI document M45-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
  • Ferber DM, Brubaker RR (1981) Plasmids in Yersinia pestis. Infection and Immunity, 31(2): 839.
  • Frean JA, Arntzen L, Capper T, Bryskier A, Klugman KP (1996) In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrobial agents and chemotherapy, 40(11): 2646-2647.
  • Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, Courvalin P (1997) Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. New England Journal of Medicine, 337(10): 677-681.
  • Galimand M, Carniel E, Courvalin P (2006) Resistance of Yersinia pestis to antimicrobial agents. Antimicrobial agents and chemotherapy, 50(10): 3233-3236.
  • Guiyoule A, Gerbaud G, Buchrieser C, Galimand M, Rahalison L, Chanteau S, ... Carniel E (2001) Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerging infectious diseases, 7(1): 43.
  • Ilyukhin V, Senina T, Andropova N (2007) Method of the accelerated preliminary estimate of sensitivity of bacteria to chemotherapy. Antibiotics and chemotherapy, 52(1-2): 18-20.
  • Inglesby TV, Dennis D, Henderson D, et al. (2000) Plague as a biological weapon: medical and public health management. JAMA 283: 2281–2290.
  • Jepras RI, Paul FE, Pearson SC, Wilkinson MJ (1997) Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry. Antimicrob. Agents Chemother., 41: 2001–2005.
  • Jorgensen J, Turnidge J (2015) Susceptibility test methods: dilution and disk diffusion methods. Manual of Clinical Microbiology: 1253-1254.
  • Kinnunen P, McNaughton BH, Albertson T, Sinn I, Mofakham S, Elbez R, ... Kopelman R (2012) Self‐assembled magnetic bead biosensor for measuring bacterial growth and antimicrobial susceptibility testing. Small, 8(16): 2477-2482.
  • Lonsway DR, Urich SK, Heine HS, McAllister SK, Banerjee SN, Schriefer ME, Patel JB (2011) Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis. Journal of clinical microbiology, 49: 1956–1960.
  • Meka-Mechenko T, Nekrassova L, Temiraliyeva G, Atshabar B, Kovaleva G (2009) Antibiotic susceptibilities of 90 isolates of Yersinia pestis to 14 antimicrobial agents. 19th European Congress of Clinical Microbiology and Infectious Diseases. Helsinki, Finland: 1386.
  • Nekrassova L, Temiralieyva G, Meka-Mechenko T, et al. (2001) Manual for study Y. pestis strains. Almaty, 39.
  • Otang-Mbeng W, Afolayan AJ (2017) Antimicrobial and Antioxidant Efficacy of Acokanthera oblongifolia Hochst (Apocynaceae). International Journal of Pharmacology, 13(8): 1086-1091.
  • Perry RD, Fetherston JD (1997) Yersinia pestis--etiologic agent of plague. Clinical microbiology reviews, 10(1): 35-66.
  • Portnoy DA, Falkow S (1981) Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. Journal of bacteriology, 148(3): 877-883.
  • Pulido MR, García-Quintanilla M, Martín-Peña R, Cisneros JM, McConnell MJ (2013) Progress on the development of rapid methods for antimicrobial susceptibility testing. Journal of Antimicrobial Chemotherapy, 68(12): 2710-2717.
  • Rasoamanana B, Coulanges P, Michel P, Rasolofonirina N (1989) Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989. Archives de l’Institut Pasteur de Madagascar, 56(1): 37-53.
  • Smith MD, Vinh DX, Nguyen TT, Wain J, Thung D, White NJ (1995) In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrobial agents and chemotherapy, 39(9): 2153-2154.
  • Steinberger-Levy I, Shifman O, Zvi A, Ariel N, Beth-Din A, Israeli O, ... Ber R (2016) A rapid molecular test for determining Yersinia pestis susceptibility to ciprofloxacin by the quantification of differentially expressed marker genes. Frontiers in microbiology, 7: 763.
  • Tunney MM, Ramage G, Field TR, et al. (2004) Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob. Ageents Chemother, 48(5): 1249-1264.
  • Urich SK, Chalcraft L, Schriefer ME, Yockey BM, Petersen JM (2012) Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia. Antimicrob Agents Chemother, 56: 555–558.
  • van Belkum A, Dunne WM (2013) Next-generation antimicrobial susceptibility testing. Journal of clinical microbiology, 51: 2018–2024.
  • Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, Rasko DA, ... Rahalison L (2007) Multiple antimicrobial resistance in plague: an emerging public health risk. PloS one, 2(3): e309.
  • Wong JD, Barash JR, Sandfort RF, Janda JM (2000) Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrobial agents and chemotherapy, 44(7): 1995-1996.
  • Zhao SS, Pulati Y, Yin XP, Li W, Wang BJ, Yang K, ... Wang YZ (2017) Wildlife Plague Surveillance near the China–Kazakhstan Border: 2012–2015. Transboundary and emerging diseases, 64(6): e48-e51.